Effects of N-Substituted Analogs of Benztropine: Diminished Cocaine-Like Effects in Dopamine Transporter Ligands

Previous studies demonstrated that analogs of benztropine (BZT) possess high affinity for the dopamine transporter, inhibit dopamine uptake, but generally have behavioral effects different from those of cocaine. One hypothesis is that muscarinic-M1 receptor actions interfere with cocaine-like effects. Several tropane-nitrogen substitutions of 4′,4′′-diF-BZT have reduced M1 affinity compared with the CH3-analog (AHN 1-055; 3α-[bis-(4-fluorophenyl)methoxy]tropane). All of the compounds displaced [3H]WIN 35,428 (2β-carbomethoxy-3β-(4-fluorophenyl)tropane) binding with affinities ranging from 11 to 108 nM. Affinities at norepinephrine ([3H]nisoxetine) and serotonin ([3H]citalopram) transporters ranged from 457 to 4810 and 376 to 3260 nM, respectively, and at muscarinic M1 receptors ([3H]pirenzepine) from 11.6 (AHN 1-055) to higher values, reaching 1030 nM for the other BZT-analogs. Cocaine and AHN 1-055 produced dose-related increases in locomotor activity in mice, with AHN 1-055 less effective than cocaine. The other compounds were ineffective in stimulating activity. In rats discriminating cocaine (29 μmol/kg i.p.) from saline, WIN 35,428 fully substituted for cocaine, whereas AHN 1-055 produced a maximal substitution of 79%. None of the other analogs fully substituted for cocaine. WIN 35,428 produced dose-related leftward shifts in the cocaine dose-effect curve, whereas selected BZT analogs produced minimal changes in the effects of cocaine. The results suggest that reducing M1 affinity of 4′,4′′-diF-BZT with N-substitutions reduces effectiveness in potentiating the effects of cocaine. Furthermore, although the BZT-analogs bind with high affinity at the dopamine transporter, their behavioral effects differ from those of cocaine. These compounds have reduced efficacy compared with cocaine, a long duration of action, and may serve as leads for the development of medications to treat cocaine abuse.

[1]  A. Newman,et al.  Evaluation of the Blood-Brain Barrier Transport, Population Pharmacokinetics, and Brain Distribution of Benztropine Analogs and Cocaine Using in Vitro and in Vivo Techniques , 2003, Journal of Pharmacology and Experimental Therapeutics.

[2]  A. Newman,et al.  Behavioral effects of rimcazole analogues alone and in combination with cocaine. , 2003, European journal of pharmacology.

[3]  A. Newman,et al.  Probes for the dopamine transporter: New leads toward a cocaine‐abuse therapeutic—A focus on analogues of benztropine and rimcazole , 2002, Medicinal research reviews.

[4]  R. Ranaldi,et al.  Self-administration of cocaine: scopolamine combinations by rhesus monkeys , 2002, Psychopharmacology.

[5]  M. Kuhar,et al.  Locomotor stimulant effects of novel phenyltropanes in the mouse. , 2001, Drug and alcohol dependence.

[6]  G. Hecht,et al.  Further studies of the reinforcing effects of benztropine analogs in rhesus monkeys , 2001, Psychopharmacology.

[7]  R. H. Kline,et al.  Dopamine transporter binding without cocaine-like behavioral effects: synthesis and evaluation of benztropine analogs alone and in combination with cocaine in rodents , 2001, Psychopharmacology.

[8]  S. Holtzman.  Differential interaction of GBR 12909, a dopamine uptake inhibitor, with cocaine and methamphetamine in rats discriminating cocaine , 2001, Psychopharmacology.

[9]  W. Bowen,et al.  N-alkyl substituted analogs of the σ receptor ligand BD1008 and traditional σ receptor ligands affect cocaine-induced convulsions and lethality in mice , 2001 .

[10]  P. Romieu,et al.  Involvement of the σ1 receptor in the cocaine‐induced conditioned place preference , 2000 .

[11]  A. Newman,et al.  Behavioral and neurochemical effects of the dopamine transporter ligand 4-chlorobenztropine alone and in combination with cocaine in vivo. , 1999, The Journal of pharmacology and experimental therapeutics.

[12]  R. H. Kline,et al.  Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter. , 1997, Journal of medicinal chemistry.

[13]  R. H. Kline,et al.  3‘-Chloro-3α-(diphenylmethoxy)tropane But Not 4‘-Chloro-3α- (diphenylmethoxy)tropane Produces a Cocaine-like Behavioral Profile† , 1997 .

[14]  M. Kuhar,et al.  Highly potent cocaine analogs cause long-lasting increases in locomotor activity. , 1996, European journal of pharmacology.

[15]  R. H. Kline,et al.  Novel 4'-substituted and 4',4"-disubstituted 3 alpha-(diphenylmethoxy)tropane analogs as potent and selective dopamine uptake inhibitors. , 1995, Journal of medicinal chemistry.

[16]  M. Kuhar,et al.  Cocaine and 3 beta-(4'-substituted phenyl)tropane-2 beta-carboxylic acid ester and amide analogues. New high-affinity and selective compounds for the dopamine transporter. , 1995, Journal of medicinal chemistry.

[17]  A. Newman,et al.  Novel 3 alpha-(diphenylmethoxy)tropane analogs: potent dopamine uptake inhibitors without cocaine-like behavioral profiles. , 1994, Journal of medicinal chemistry.

[18]  M. Pontecorvo,et al.  Selective σ ligands block stimulant effects of cocaine , 1991 .

[19]  M. J. Kuhar,et al.  The dopamine hypothesis of the reinforcing properties of cocaine , 1991, Trends in Neurosciences.

[20]  J. Stevens.  Intermediate Statistics: A Modern Approach , 1990 .

[21]  W. H. Morse,et al.  Effects of norcocaine and some norcocaine derivatives on schedule-controlled behavior of pigeons and squirrel monkeys. , 1979, The Journal of pharmacology and experimental therapeutics.

[22]  R. T. Kelleher,et al.  Some effects of cocaine and two cocaine analogs on schedule-controlled behavior of squirrel monkeys. , 1977, The Journal of pharmacology and experimental therapeutics.

[23]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[24]  C. Schuster,et al.  Cholinergic influence on intravenous cocaine self-administration by rhesus monkeys. , 1973, Pharmacology, biochemistry, and behavior.

[25]  G. W. Snedecor.  STATISTICAL METHODS , 1967 .

[26]  C. Scheckel,et al.  Behavioral effects of interacting imipramine and other drugs with d-amphetamine, cocaine, and tetrabenazine , 1964, Psychopharmacologia.

[27]  P. L. Carlton,et al.  Augmentation of the behavioral effects of amphetamine by atropine. , 1961, The Journal of pharmacology and experimental therapeutics.

[28]  J. O. Irwin,et al.  Statistical Method in Biological Assay , 1953, Nature.

[29]  J. Miller,et al.  N-alkyl substituted analogs of the sigma receptor ligand BD1008 and traditional sigma receptor ligands affect cocaine-induced convulsions and lethality in mice. , 2001, European journal of pharmacology.

[30]  P. Romieu,et al.  Involvement of the sigma1 receptor in the cocaine-induced conditioned place preference. , 2000, Neuroreport.

[31]  R. H. Kline,et al.  3’- and 4’-chloro-substituted analogs of benztropine: intravenous self-administration and in vitro radioligand binding studies in rhesus monkeys , 2000, Psychopharmacology.

[32]  R. H. Kline,et al.  Novel 3alpha-diphenylmethoxytropane analogs: selective dopamine uptake inhibitors with behavioral effects distinct from those of cocaine. , 1999, The Journal of pharmacology and experimental therapeutics.

[33]  M. Pontecorvo,et al.  Selective sigma ligands block stimulant effects of cocaine. , 1991, European journal of pharmacology.

[34]  S. Enna,et al.  Antidepressants : neurochemical, behavioral, and clinical perspectives , 1981 .